Company confirmed from its website. How we verify
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience. It applies its neuroscience expertise to develop medicines for complex and difficult-to-treat psychiatric and neurological disorders. Its pipeline includes alixorexton, an investigational oral orexin 2 receptor agonist studied for narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia, and olanzapine and samidorphan, being evaluated for pediatric use in a phase 3 study.
Description based on the company's website.
Products manufactured
Product illustrations, until the company adds its own photos.
Tritonis verification index
How the index is calculatedLittle verifiable information so far. The company can complete its listing for free.
The factor-by-factor breakdown, the comparison of your suppliers and alerts are reserved for buyer accounts. See the details and compare
Request a quote
Describe what you need: your request is sent to Alkermes plc, who can reply to you directly.
Spotted an error on this listing?
Report it: we review every report, usually within two business days. No account is needed.
Source: Connecticut Secretary of the State, Business Registry (public domain).
Recently viewed
